Search
Oculis Holding AG
OCSAdd to Watchlist
11.660USD
+0.440+3.92%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
684.30MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
12
analysts
Strong Buy
Current Rating
39.800
Target Price
+254.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Oculis Holding AG
OCS
12
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Oculis Holding AG's expected revenue for the next quarter?
Oculis Holding AG's expected revenue is 238.84K.
What is Oculis Holding AG's price target?
Analysts forecast that Oculis Holding AG's price target is USD 36.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 30.00.
How have Oculis Holding AGOCS's recent earnings per share performed?
The market expectation was USD -0.61, while Oculis Holding AGOCS's earnings per share (EPS) for the previous quarter was USD -0.53. EPS for the next quarter is expected at USD -0.52.
What is the analyst rating for Oculis Holding AG?
Based on the ratings of Oculis Holding AG's stock from 12 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
